HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,142 | -1.2% | 2,424 | -6.1% | 0.01% | 0.0% |
| Q2 2023 | $219,746 | -1.8% | 2,581 | -4.5% | 0.01% | -14.3% |
| Q1 2023 | $223,673 | -16.0% | 2,703 | -20.2% | 0.01% | -17.6% |
| Q4 2022 | $266,309 | +0.9% | 3,386 | -5.1% | 0.02% | -10.5% |
| Q3 2022 | $264,000 | +7.3% | 3,569 | -5.6% | 0.02% | +18.8% |
| Q2 2022 | $246,000 | -22.9% | 3,781 | -25.1% | 0.02% | +23.1% |
| Q1 2022 | $319,000 | +29.7% | 5,051 | +8.9% | 0.01% | +62.5% |
| Q4 2021 | $246,000 | -22.6% | 4,637 | +2.8% | 0.01% | -27.3% |
| Q3 2021 | $318,000 | -2.5% | 4,510 | -7.8% | 0.01% | 0.0% |
| Q2 2021 | $326,000 | -13.5% | 4,893 | +44.3% | 0.01% | -21.4% |
| Q1 2021 | $377,000 | -12.5% | 3,392 | -6.5% | 0.01% | -26.3% |
| Q4 2020 | $431,000 | +32.6% | 3,629 | -2.6% | 0.02% | +11.8% |
| Q3 2020 | $325,000 | +21.7% | 3,724 | +25.0% | 0.02% | +13.3% |
| Q2 2020 | $267,000 | -17.3% | 2,980 | -8.2% | 0.02% | -37.5% |
| Q1 2020 | $323,000 | -51.7% | 3,246 | -44.3% | 0.02% | -17.2% |
| Q4 2019 | $669,000 | -2.2% | 5,823 | +7.4% | 0.03% | -17.1% |
| Q3 2019 | $684,000 | -13.9% | 5,423 | -17.8% | 0.04% | -7.9% |
| Q2 2019 | $794,000 | +30.2% | 6,599 | -5.3% | 0.04% | +31.0% |
| Q1 2019 | $610,000 | +13.2% | 6,971 | +29.4% | 0.03% | -12.1% |
| Q4 2018 | $539,000 | -41.7% | 5,389 | -33.2% | 0.03% | -5.7% |
| Q3 2018 | $924,000 | +24.7% | 8,068 | -2.3% | 0.04% | +16.7% |
| Q2 2018 | $741,000 | -8.2% | 8,261 | -25.1% | 0.03% | -6.2% |
| Q1 2018 | $807,000 | +51.4% | 11,028 | +20.1% | 0.03% | +52.4% |
| Q4 2017 | $533,000 | +24.5% | 9,180 | -3.8% | 0.02% | +16.7% |
| Q3 2017 | $428,000 | +5.4% | 9,540 | -7.2% | 0.02% | 0.0% |
| Q2 2017 | $406,000 | -14.2% | 10,276 | -11.8% | 0.02% | -14.3% |
| Q1 2017 | $473,000 | -17.2% | 11,648 | -18.0% | 0.02% | -19.2% |
| Q4 2016 | $571,000 | +42.8% | 14,208 | +28.6% | 0.03% | +36.8% |
| Q3 2016 | $400,000 | -1.2% | 11,044 | -20.9% | 0.02% | -5.0% |
| Q2 2016 | $405,000 | -16.3% | 13,954 | +0.9% | 0.02% | -20.0% |
| Q1 2016 | $484,000 | +54.6% | 13,830 | +42.4% | 0.02% | +66.7% |
| Q4 2015 | $313,000 | +5.4% | 9,711 | +5.6% | 0.02% | -11.8% |
| Q3 2015 | $297,000 | -48.5% | 9,193 | -34.2% | 0.02% | -29.2% |
| Q2 2015 | $577,000 | -16.6% | 13,961 | -9.4% | 0.02% | -11.1% |
| Q1 2015 | $692,000 | +67.6% | 15,411 | +39.5% | 0.03% | +58.8% |
| Q4 2014 | $413,000 | +35.0% | 11,045 | +25.9% | 0.02% | +21.4% |
| Q3 2014 | $306,000 | -31.7% | 8,776 | -30.9% | 0.01% | -30.0% |
| Q2 2014 | $448,000 | -2.8% | 12,702 | -10.2% | 0.02% | -4.8% |
| Q1 2014 | $461,000 | -58.7% | 14,147 | -46.6% | 0.02% | -58.0% |
| Q4 2013 | $1,115,000 | +91.9% | 26,471 | +81.7% | 0.05% | +61.3% |
| Q3 2013 | $581,000 | +16.0% | 14,570 | +20.3% | 0.03% | -11.4% |
| Q2 2013 | $501,000 | – | 12,110 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |